Arcadia Biosciences Cash Flow - Annual (NASDAQ:RKDA)

Add to My Stocks
$0.9 $0.06 (6.05%) RKDA stock closing price Jan 17, 2017 (Closing)

The Arcadia Biosciences cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. This statement shows details about the cash generated and spent during a particular quarter, while the other two statements give details about Arcadia Biosciences profits and Arcadia Biosciences debt. This statement can tell if a company is running out of money while still being profitable and is useful in Arcadia Biosciences stock analysis. Arcadia Biosciences had a negative net income cash flow of $-17.95M for the latest year. This report is very useful in measuring the short term viability of a company. Arcadia Biosciences had an outflow of $0.32M from operating activities, $38.76M inflow due to financing activities, and $44.77M spend due to investing activities for 2015. View details of Arcadia Biosciences cash flows for latest & last ten financial years.

show more
Fiscal year is Jan - Dec. 2015 2014 2013
Arcadia Biosciences Net Income Cash Flow
-17.95M-18.33M-13.19M
Depreciation Depletion Amortization Cash-Flow0.37M0.35M0.39M
Net Increase (Decrease) in Assets Liabilities-0.05M-1.33M-0.14M
Cash From (used in) Discontinued Operations---
Other Adjustments Net2.52M4.53M3.2M
Arcadia Biosciences Net Cash from (used by) Operating Activities
-15.1M-14.78M-9.74M
Increase (Decrease) in Prop Plant And Equipment-0.14M-0.14M-0.1M
Acquisition Disposition of Subsidiaires--1.45M-0.5M
Increase (Decrease) in Investments-46.21M--
Other Cash Inflow (Outflow) from Investment Activities---
Arcadia Biosciences Net Cash from (used by) Invesment Activities
-46.36M-1.59M-0.6M
Issuance (Purchase) of Equity Shares68.58M32.86M0.01M
Issuance (Repayment) of Debt Securities10.2M-1.15M7.83M
Increase (Decrease) in Bank & Other Borrowings---
Payment of Dividends & Other Cash Distributions---
Other Cash from (used by) Financing Activities
Arcadia Biosciences Net Cash from (used by) Financing Activities
68.87M30.11M7.83M
Effect of Exchange Rate Changes on Cash---
Arcadia Biosciences Net Change in Cash & Cash Equivalents
7.4M13.73M-2.51M
Cash & Equivalents at Beginning of Year16.57M2.83M5.35M
Cash & Equivalents at Year End23.97M16.57M2.83M
All figures in USD. M: Millions of USD, B: Billions of USD.
Get Cash flow for another ticker

Arcadia Biosciences stock price history provides insight into historical stock price fluctuations, and Arcadia Biosciences stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:
  • Arcadia Biosciences had a Net Change in Cash and Cash Equivalents of $7.4M for the latest year 2015. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Arcadia Biosciences stock price , albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a negative value of $-15.1M for RKDA.
  • Growth companies (typically most tech companies) spend heavily  on investing activities and this figure was negative at $-46.36M for RKDA stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $68.87M for Arcadia Biosciences. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.
.

Key Financial Ratios For Arcadia Biosciences Cash Flow

FCF margin
-3.67